G L Scheffer
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 13
-
- Cancer therapeutics and mechanisms 3
- DNA Repair Mechanisms 2
- RNA Interference and Gene Delivery 2
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Elisabeth G.E. de Vries (5 shared papers)Paul van der Valk (5 shared papers)Rik J. Scheper (4 shared papers)H J Broxterman (1 shared paper)Marilyn L. Slovak (1 shared paper)William S. Dalton (1 shared paper)Patricia Kaaijk (1 shared paper)C.K. van Kalken (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Journal of Clinical Pathology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Blood (1 paper)PubMed (8 papers)
- Partner nations
- NetherlandsUnited StatesSpain
In The Last Decade
G L Scheffer
14 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 82
- Oncology 1.3k
- Pediatrics, Perinatology and Child Health 308
- Hematology 167
- Molecular Biology 780
- Genetics 107
Countries citing papers authored by G L Scheffer
This map shows the geographic impact of G L Scheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G L Scheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G L Scheffer more than expected).
Fields of papers citing papers by G L Scheffer
This network shows the impact of papers produced by G L Scheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G L Scheffer. The network helps show where G L Scheffer may publish in the future.
Co-authors
The 25 scholars most cited alongside G L Scheffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. | 1993 | 433 |
| 2 | 1996 | 209 | |
| 3 | 1995 | 190 | |
| 4 | The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. | 2001 | 174 |
| 5 | Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. | 2000 | 147 |
| 6 | 2002 | 135 | |
| 7 | Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. | 1999 | 91 |
| 8 | The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. | 1995 | 82 |
| 9 | A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. | 2001 | 73 |
| 10 | Membrane transport proteins associated with drug resistance expressed in human melanoma. | 1995 | 72 |
| 11 | 1996 | 39 | |
| 12 | Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. | 1998 | 21 |
| 13 | 2002 | 13 | |
| 14 | 2002 | 7 |
About G L Scheffer
G L Scheffer is a scholar working on Oncology, Molecular Biology, Surgery, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), Amino Acid Enzymes and Metabolism (3 papers), DNA Repair Mechanisms (2 papers), RNA Interference and Gene Delivery (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pediatrics, Perinatology and Child Health (308 citations), Hematology (167 citations), Molecular Biology (780 citations) and Genetics (107 citations). G L Scheffer has collaborated with scholars based in Netherlands, United States and Spain. Frequent co-authors include Elisabeth G.E. de Vries, Paul van der Valk, Rik J. Scheper, H J Broxterman, Marilyn L. Slovak, William S. Dalton, Patricia Kaaijk, C.K. van Kalken, R J Scheper and M J Flens. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Pathology, JNCI Journal of the National Cancer Institute, Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.